What Roemmers SAICF does

Roemmers SAICF is a privately held Argentine pharmaceutical company headquartered in Olivos, Argentina, founded in 1921. The company self-identifies as a leader in the Argentine pharmaceutical industry and operates with a workforce of 1,001–5,000 employees, placing it among the larger pharmaceutical employers in the country. Based on its scale and incumbency, it almost certainly manufactures, markets, and distributes a broad portfolio of branded and generic pharmaceutical products serving physicians, pharmacies, hospitals, and ultimately patients across Argentina, though the specific product mix, therapeutic areas, and SKU count are not documented in the available source data.

The company's business model is consistent with the traditional Argentine pharmaceutical industry structure: developing or licensing molecules, obtaining regulatory approval through ANMAT, manufacturing under GMP conditions, and distributing through wholesalers (droguerías) and direct pharmacy/hospital channels. With over a century of operating history, Roemmers has accumulated brand equity, manufacturing capacity, regulatory registrations, and distribution relationships that constitute meaningful competitive assets. Its website domain (roemmers.com.ar) is the primary disclosed digital channel, though the source data shows the site returning a loading/verification page rather than substantive product or financial information.

Revenue mechanics, pricing strategy, customer segmentation, channel mix, R&D pipeline, and specific competitive positioning are not documented in the source material. There is no disclosed revenue figure, no product catalog, no customer logo information, no partnership announcements, no M&A history, and no management team roster. As a private 100+ year old enterprise, the company does not face public reporting requirements, which contributes to the thin information environment. Any deeper analysis would require primary research, distributor data, ANMAT filings, or management dialogue.

Name

Roemmers SAICF

Website

https://roemmers.com.ar

Company type

Private

Founded year

1921

Headcount range

1,001–5,000 employees

Short description

Roemmers SAICF is a privately held Argentine pharmaceutical company founded in 1921, headquartered in Olivos, and operating with 1,001–5,000 employees as a self-described leader in the Argentine pharmaceutical industry, serving physicians, pharmacies, and patients across Argentina.

Ownership category

akta.pro rank

Headquarters

HQ city

Olivos

HQ country

Argentina

HQ region

Latin America

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Core offering

Roemmers SAICF is a pharmaceutical company operating in Argentina, manufacturing and distributing pharmaceutical products. Founded in 1921 and headquartered in Olivos, the firm is described as a leader in the Argentine pharmaceutical industry, employing between 1,001 and 5,000 people and producing medicines for the domestic market.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Direct peers

• Laboratorios Montpellier: Argentine pharmaceutical manufacturer with a prescription drug focus, competing with Roemmers for physician share and pharmacy shelf space in Argentina.
• Gador: Argentine pharmaceutical laboratory competing head-to-head with Roemmers in branded prescription and specialty pharma, with comparable manufacturing scale and physician-channel relationships.
• Laboratorios Elea: Major Argentine pharmaceutical company with branded prescription and consumer health products, directly comparable to Roemmers in product mix, channel strategy, and Argentine market positioning.
• Laboratorios Bagó: One of Argentina's largest pharmaceutical manufacturers and Roemmers' closest domestic competitor, with overlapping branded generics, prescription, and specialty portfolios and similar Argentine-centric distribution.

Regional players

• Eurofarma: Brazilian pharmaceutical multinational with a growing Latin American footprint, a relevant regional peer as Argentine pharma companies like Roemmers evaluate expansion beyond domestic borders.

Broad incumbents

• Teva Pharmaceutical: World's largest generic drug manufacturer with commercial presence across Latin America, competing with Roemmers in generics and select specialty categories.
• Bayer (Argentina): Global pharmaceutical and consumer health major with established Argentine operations, competing across prescription, OTC, and consumer health segments where Roemmers also plays.
• Sanofi (Argentina): Global pharmaceutical and vaccines company with consumer health and prescription operations in Argentina, comparable in scale and product overlap to Roemmers' portfolio.
• Pfizer (Argentina): Multinational pharmaceutical leader with Argentine commercial presence, competing in branded specialty and primary care categories that overlap with Roemmers' portfolio.
• Roche (Argentina): Global pharmaceutical major with Argentine operations across specialty and oncology therapeutics, increasingly relevant as biosimilars and specialty pharma expand in Argentina.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks3 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roemmers SAICF